LFFM Fundraising Event Again Reaches a Record Setting Year
By Pamela Goldsmith, MRA Director of Communications | 6 June 2017 In Allies & Partnerships, Events
Nearly 1,000 professionals from the leveraged finance community gathered for the sixth annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party raising a record $1.8 million in funds for the Melanoma Research Alliance (MRA), the largest private funder of melanoma research.
What Gut Bacteria Tell Us About Treating Melanoma and Other Cancers
By Pamela Goldsmith, MRA Director of Communications | 3 April 2017 In News, Science, Treatment
Despite success in the use of immunotherapy to treat cancer by harnessing the body’s immune system to fight it, a major difficulty continues to be the range of responses to treatment among patients. It’s why researchers are exploring why some cancer patients exhibit astounding results with little side effects while others receive no benefits to the treatment and/or experience severe side effects.
MRA and BJ’s Wholesale Club Partner to Launch May Campaign
By Pamela Goldsmith, MRA Director of Communications | 3 April 2017 In Allies & Partnerships, Prevention
In today’s dynamic research environment, working as a team is more valuable than ever. This May, in an effort to spotlight Melanoma Awareness month, BJ’s Wholesale Club, a warehouse club operating in 15 states and headquartered in Massachusetts, will launch its first awareness campaign in partnership with MRA to highlight the importance of prevention.
Taking Charge of the Skin You’re In: 3 Levels of Melanoma Prevention and Detection
By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 3 April 2017 In Melanoma Stories, Prevention, Treatment
No healthy person in their twenties expects they’re going to get a call one day telling them they have an invasive nodular melanoma. Despite seeing and hearing of horrible stories about young patients developing cancers, we can’t imagine it’ll happen to us. That element of surprise is exactly what 25-year-old medical student, Alissa Prior, experienced upon hearing her diagnosis.
Finance Industry Rallies to Fight Melanoma
By Rachel Gazzerro, MRA Associate Director, Development & Information Management | 3 April 2017 In Allies & Partnerships, Events
Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event, sponsored annually in New York City by the Melanoma Research Alliance (MRA) has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities – all gathered together in response to melanoma.
Polka Dot Mama Melanoma Foundation Launches Shade Shuttle Bus Tour
By Pamela Goldsmith, MRA Director of Communications | 2 April 2017
Taking her advocacy to the next level, Tracy Callahan, along with the Tara Miller Melanoma Foundation, is about to launch Shade Shuttle, a multi-state bus tour dedicated to raising awareness and educating the community about melanoma.
Trena's Story: An African-American Retiree's Journey with Melanoma
8 June 2016 In Melanoma Stories
“Trena, you have melanoma and you are going to lose your toe. “ WHAT?!?! I am a Black woman in her sixties—that is crazy!!
Is a Clinical Trial Right for You?
By Cody R. Barnett, MRA Director of Communications | 11 December 2015 In Science, Treatment
Clinical trials are key to bringing new treatments to patients, as we have seen with melanoma. Are they right for you?
Spotlight on MRA’s Ninth Annual Scientific Retreat
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 February 2017 In Allies & Partnerships, Events, Science
In mid-February, MRA held its premiere research event — the 9th Annual Scientific Retreat, in Washington, DC. A total of 297 individuals registered for the meeting representing a spectrum of key stakeholders in melanoma including academic investigators, pharmaceutical and biotech company representatives, melanoma advocates from various different non-profit organizations, donors and government officials.
Melanoma Prevention: The Latest Advances & Future Directions
By Pamela Goldsmith, MRA Director of Communications | 28 February 2017 In Events, Policy, Prevention, Science
During my interview with Susan Swetter, MD, Professor of Dermatology,
Stanford University and VA Palo Alto, at the Melanoma Research Alliance Ninth Annual Scientific Retreat in Washington, DC, I inquired about the Panel Discussion she was part of titled: News from the field: What’s going well and what remains to be done?